1-6 of 6
Steven M. Kornblau
Close
Sort by
Journal Articles

High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse

Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Marina Konopleva, Nitin Jain, Rashmi Kanagal-Shamanna, Keyur P. Patel, Walid Macaron, Tapan M. Kadia, Sa Wang, Jeffrey L. Jorgensen, Joseph D. Khoury, Musa Yilmaz, Partow Kebriaei, Koichi Takahashi, Guillermo Garcia-Manero, Naval Daver, Sean M. Post, Xuelin Huang, Steven M. Kornblau, Sara Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Elias Jabbour
Journal: Blood Advances
Blood Adv (2022) 6 (13): 4006–4014.
https://doi.org/10.1182/bloodadvances.2022007378
Published: 2022
Includes: Supplemental data
Journal Articles

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy

Hussein A. Abbas, Zoe Alaniz, Sean Mackay, Matthew Cyr, Jing Zhou, Ghayas C. Issa, Mansour Alfayez, Jairo Matthews, Steven M. Kornblau, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Naval Daver
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4569–4574.
https://doi.org/10.1182/bloodadvances.2021004583
Published: 2021
Includes: Supplemental data
Journal Articles

Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia

Allison J. Kaeding, Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo, Robert B. Gerbing, Colin Correnti, Michael R. Loken, Lisa Eidenschink Broderson, Laura Pardo, Quy H. Le, Thao Tang, Amanda R. Leonti, Jenny L. Smith, Cassie K. Chou, Min Xu, Tim Triche, Jr, Steven M. Kornblau, E. Anders Kolb, Katherine Tarlock, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2350–2361.
https://doi.org/10.1182/bloodadvances.2021004424
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical value of event-free survival in acute myeloid leukemia

Clinical Trials & Observations
Abhishek Maiti, Hagop M. Kantarjian, Vinita Popat, Gautam Borthakur, Guillermo Garcia-Manero, Marina Y. Konopleva, Courtney D. DiNardo, Srdan Verstovsek, Michael Andreeff, Tapan M. Kadia, Helen O. Ajufo, Rohit V. Goswamy, Carlos Blanco, Miguel Velasquez, Naval G. Daver, Naveen Pemmaraju, Sherry R. Pierce, William G. Wierda, Steven M. Kornblau, Farhad Ravandi, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1690–1699.
https://doi.org/10.1182/bloodadvances.2019001150
Published: 2020
Includes: Supplemental data
Journal Articles

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

Clinical Trials & Observations
Nicholas J. Short, Keyur P. Patel, Maher Albitar, Miguel Franquiz, Rajyalakshmi Luthra, Rashmi Kanagal-Shamanna, Feng Wang, Rita Assi, Guillermo Montalban-Bravo, Jairo Matthews, Wanlong Ma, Sanam Loghavi, Koichi Takahashi, Ghayas C. Issa, Steven M. Kornblau, Elias Jabbour, Guillermo Garcia-Manero, Hagop M. Kantarjian, Zeev Estrov, Farhad Ravandi
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1670–1677.
https://doi.org/10.1182/bloodadvances.2019001156
Published: 2020
Includes: Supplemental data
Journal Articles

Co-occurrence of FLT3 -TKD and NPM1 mutations defines a highly favorable prognostic AML group

Clinical Trials & Observations
Prajwal Boddu, Hagop Kantarjian, Gautam Borthakur, Tapan Kadia, Naval Daver, Sherry Pierce, Michael Andreeff, Farhad Ravandi, Jorge Cortes, Steven M. Kornblau
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1546–1550.
https://doi.org/10.1182/bloodadvances.2017009019
Published: 2017
Includes: Supplemental data